Subscribe To
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today announced the pricing of its underwritten public offering of 8,333,334 shares of its common stock at a price to the public of $30.00 per […] The post Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants appeared first on ForexTV...
Read More
Posted: Oct 19 2023, 01:16
Author Name: forextv
Views: 082398